The raubasine market is expected to grow at a significant CAGR during the forecast period (2021-2027). Raubasine (ajmalicine), a Rauwolfia alkaloid, has been discovered to have a wide range of applications in the treatment of circulatory disorders, particularly in the alleviation of blockage of normal cerebral blood flow. It has been used to treat high blood pressure when combined with other Rauwolfia alkaloids. Raubasine is an antihypertensive medication used to treat hypertension. Card-Lamuran, Circolene, Cristanyl, Duxil, Duxor, Hydroxysarpon, Iskedyl, Isosarpan, Isquebral, Lamuran, Melanex, Saltucin Co, Salvalion, and Sarpan are some of the brand names used. Raubasine is an antagonist for the alpha 1-adrenergic receptor.
To Request a Sample of our Report on Global Raubasine Market: https://www.omrglobal.com/request-sample/raubasine-marketBlood pressure is defined as the pressure exerted on the artery walls by the blood during the transportation of blood from the heart to the rest of the body. Hypertension is a commonly known condition of high blood pressure which may cause harm to the heart and also cause other health concerns. Hypertension was the major cause for half of the fatalities in the US in 2019 as per records stated by the CDC. Almost half of the population (47%) in the US are said to be suffering from hypertension and are on medication. Only roughly 1/4th of individuals with hypertension (24 %) have their condition under control.
Blood pressure of 140/90 mmHg or greater is found in around half of the people (45%) with uncontrolled hypertension. This comprises 37 million adults in the US. Approximately 34 million individuals who have been advised to take medicine may require a prescription. A blood pressure of 140/90 mmHg or above affects about two-thirds of this population (19 million). In the US in 2019, high blood pressure was a main or contributing cause of death for 516,955 persons. Therefore, the rising prevalence of hypertension is expected to drive the market for Raubasine globally.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered–
- By Type
- By Application
Regions Covered
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape: Indo Phytochem Pharmaceuticals, Johnson & Johnson Ltd., Merck & Co., Novartis AG, Pfizer, Inc., Quad Life Sciences Private Limited,
(Get 15% Discount on Buying this Report)
A full Report of Global Raubasine Market is Available at: https://www.omrglobal.com/industry-reports/raubasine-market
Global Raubasine Market by Segments
By Type
- Injectable
- Tablets
By Application
- Anti-Hypertension
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
